Subjects showing persistent hyperglycemia ( glycated hemoglobin -LSB- HbA@c -RSB- @ % and @ % ) were then randomly assigned to CSII or continuing an MDI regimen for a @-month phase followed by a single crossover of the MDI arm , switching to CSII .